Journal of Clinical Oncology

Vol. 43, Issue 16_suppl Issue 16_suppl 2025
6439
Articles

Articles in this Issue

Language matters: Impact of medical interpretation on lung cancer screening adherence.

Dan Chen Qu, Clara J. Oh, Chinmay Jani et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e13752

e13752 Background: Landmark trials like NLST, NELSON, DLCST, DANTE, PLCO, and LUSI have shown benefits of lung cancer screening (LCS) in early detection a...

Efficacy and safety of nivolumab and ipilimumab in treating metastatic colorectal cancer (mCRC): A systematic review and meta-analysis.

Muhammad Ahmad Sohail, Syed Sibt E Haider, Mustafa Iqbal Khan et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e15560

e15560 Background: Colorectal cancer is among the top three cancers in the world with approximately a million new cases each year globally. Immunotherapie...

Prognosis and survival evaluation in treating high-risk BRAF V600 mutation stage III or IV melanoma with dabrafenib plus trametinib therapy: A meta-analysis of 2,660 patients.

Arturo Ortiz, Aldo Ascencio, Diego Pichardo Rojas et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e21501

e21501 Background: Stage III and IV melanoma is a challenging entity due to its high mortality rate, rapid progression, and therapy resistance. For patien...

Ensartinib as postoperative adjuvant therapy in patients with ALK-positive non-small cell lung cancer (NSCLC): A registered, retrospective, real-world study.

Lin Wang, Jing Zhang, Sihua Wang et al. Jun 01, 2025 pp. 8024-8024 10.1200/jco.2025.43.16_suppl.8024

8024 Background: Ensartinib has been approved as ALK-positive locally advanced/metastatic NSCLC, but its role in adjuvant therapy remains unknown. This re...

Evaluating the feasibility of a peer-support group for patients with cancer (presently).

Brandon Anderson, Errol James Philip, Olga Egorova et al. Jun 01, 2025 pp. 12101-12101 10.1200/jco.2025.43.16_suppl.12101

12101 Background: Many patients with cancer experience significant mental health challenges (commonly depression, anxiety, and adjustment disorders) which...

Cervical cancer treatment trajectories in a sample of cervical cancer patients in the Democratic Republic of the Congo: A retrospective descriptive study.

Jonas M. Ndeke, Jonathan T. Macy, James E. Klaunig et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e17519

e17519 Background: With limited curative-intent treatment options in the country, cervical cancer is the leading cancer in terms of mortality in the Democ...

Diagnosis, treatment, and outcomes of multiple myeloma in Armenia: A real-world experience from a developing country.

Samvel Bardakhchyan, Nerses Ghahramanyan, Astghik Voskanyan et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e19513

e19513 Background: In Armenia, multiple myeloma (MM) is one of the most frequent hematologic malignancies. The aim of this study is to evaluate diagnostic...

Comparative diagnostic accuracy of deep learning and hand-crafted radiomics models for detecting lymph node metastases in head and neck cancers: A meta-analysis.

Abdur Rehman, Shahzaib Maqbool, Imran Khan et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e18023

e18023 Background: Accurate detection of lymph node metastases (LNM) is crucial in the management of head and neck cancers. Artificial intelligence (AI) t...

Immunoembolization for patients with uveal melanoma hepatic metastasis: A single-institution real-world data analysis.

Rino S. Seedor, David J. Eschelman, Carin F. Gonsalves et al. Jun 01, 2025 pp. 9586-9586 10.1200/jco.2025.43.16_suppl.9586

9586 Background: Metastatic disease occurs in up to 50% of patients with uveal melanoma (UM) despite successful treatment of the primary eye tumor. The li...

Receiving a cancer diagnosis during hospitalization and associations with care outcomes.

Saurav Kadatane, Jonathan Liles, Anh B. Lam et al. Jun 01, 2025 pp. 11046-11046 10.1200/jco.2025.43.16_suppl.11046

11046 Background: Patients often receive their cancer diagnoses during a hospitalization, but little is known about patients who are diagnosed inpatient v...

Fixed duration subcutaneous (SC) mosunetuzumab (Mosun) in patients with previously untreated high-tumor burden follicular lymphoma (FL): Interim results from the phase II MorningSun study.

Ian W. Flinn, John M. Burke, Jeff Porter Sharman et al. Jun 01, 2025 pp. 7014-7014 10.1200/jco.2025.43.16_suppl.7014

7014 Background: Mosun is a CD20xCD3 bispecific antibody that can be administered in the outpatient setting for a fixed duration. Intravenous Mosun is app...

Trajectories of clinical encounters among long-term lung cancer survivors: A SEER-Medicare cluster analysis.

Yiye Zhang, Hao Zhang, William E. Rosa et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e13633

e13633 Background: With improved lung cancer survival, there is a knowledge gap in the variations in clinical needs and healthcare utilization among long-...

Medical students’ interest and exposure to oncology in Nigeria: Implications for workforce development.

Nwamaka Lasebikan, Kosisochukwu Udeogu, Foluke Oladele Sarimiye Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e21036

e21036 Background: Oncology workforce shortages pose a significant challenge to cancer care in low- and middle-income countries (LMICs). In Nigeria, a cou...

Differences in patient (pt) characteristics and therapy choice across treatment (tx) groups in locally advanced or metastatic urothelial cancer (la/mUC) in the US: A survey on unmet patient needs.

Neil Milloy, Cameron Forshaw, Maria Walley et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e16561

e16561 Background: Although the tx landscape for la/mUC has evolved with the emergence of novel therapies, a gap remains in understanding physician perspe...

Hyperthermic intraperitoneal chemotherapy (HIPEC) for primary advanced-stage or recurrent ovarian cancer: A systematic review and meta-analysis of randomized controlled trials.

Gabriela Branquinho Guerra, Camila Mariana De Paiva Reis, Junior Samuel Alonso de Menezes et al. Jun 01, 2025 pp. 5583-5583 10.1200/jco.2025.43.16_suppl.5583

5583 Background: Ovarian cancer is the gynecologic malignancy with the highest mortality rate. Despite cytoreductive surgery (CRS) and adjuvant or neoadju...

Immunoprofiling: A prospective multi-cohort study to characterize circulating immune response in advanced prostate cancer.

Paloma Galera, Patricia Toquero, Luis San José Manso et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e17055

e17055 Background: The tumor immune microenvironment (TIME) is a critical determinant of therapeutic response and resistance mechanisms in prostate cancer...

Impact of clinical and socioeconomic factors on survival outcomes in non-small cell lung cancer: A retrospective analysis.

Harsh Bhalala, Mina Aiad, John Santare et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e13548

e13548 Background: Lung cancer is the most common cause of cancer-related mortality in the United States. Research suggests that not only clinical factors...

Differential genomic landscape of estrogen receptor (ER)-low versus ER-positive (ER+) and ER-negative (ER-) metastatic breast cancer (MBC).

Chiara Corti, Sreekar Challa, Ningxuan Zhou et al. Jun 01, 2025 pp. 1071-1071 10.1200/jco.2025.43.16_suppl.1071

1071 Background: Guidelines define ER+ breast cancer (BC) as ≥1% tumor nuclei staining positive by IHC. Data on managing ER-low tumors (1–10% ER staining)...

Temporal trends and disparities in pancreatic cancer mortality: A nationwide analysis from 1968-2020.

Muhammad Ahmad, Malik WZ Khan, Abdul Wali Khan et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e16428

e16428 Background: Pancreatic cancer is among the most aggressive malignancies, with poor survival rates and a rising incidence globally. Understanding lo...

Induction chemotherapy for locally advanced sinonasal carcinoma: A systematic review and meta-analysis.

Atif Butt, Muhammad Fareed Khalid, Ammad Naeem et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e18160

e18160 Background: Induction chemotherapy (IC) has emerged as a promising approach in the management of locally advanced sinonasal carcinoma. Recent studi...

Novel liquid biopsy method for detecting androgen receptor splice variant 7 in circulating tumor cells of mCRPC.

Hoin Kang, Jihyun Lee, Minseon Hwang et al. Jun 01, 2025 10.1200/jco.2025.43.16_suppl.e14542

e14542 Background: Androgen receptor splice variant 7 (AR-V7) is constitutively activated isoform of AR and has been associated with the resistance toward...

Combining abemaciclib, temozolomide, and radiation in DIPG PDOX models: Insights from single-cell RNA-seq on cellular subtypes and genes critical for responsiveness and resistance.

Zilu Huang, Tongchao Jiang, Milagros Melanie Suarez Palacios et al. Jun 01, 2025 pp. 2073-2073 10.1200/jco.2025.43.16_suppl.2073

2073 Background: Diffuse intrinsic pontine glioma (DIPG) is a highly aggressive pediatric brain tumor, with two-year survival less than 10%. Radiation the...

Tumor flare reactions secondary to T-cell engaging immunotherapies: A study from the French REISAMIC registry.

Alexandre Xu-Vuillard, Matthieu Roulleaux Dugage, Thomas Hueso et al. Jun 01, 2025 pp. 2645-2645 10.1200/jco.2025.43.16_suppl.2645

2645 Background: Tumour flare reactions (TFR) were recently reported in patients receiving T-cell engagers (TCE) and require further investigations. This...

Neurocognitive outcomes following 30.6-Gy whole-ventricular radiotherapy with 54-Gy total dose focal tumor bed boost for CNS non-germinomatous germ cell tumors: A Children’s Oncology Group study (ACNS1123).

Sunita K. Patel, Yu Wang, Christine L. Trask et al. Jun 01, 2025 pp. 10036-10036 10.1200/jco.2025.43.16_suppl.10036

10036 Background: COG ACNS1123 stratum 1 was a prospective, phase II trial treating children with localized non-germinomatous germ cell tumors of the brai...

Enhancing radiotherapy planning skills through structured deliberate practice and artificial intelligence integration: A pilot study.

Ivy Weishan Ng, Yu Yang Soon, Francis Ho et al. Jun 01, 2025 pp. 9019-9019 10.1200/jco.2025.43.16_suppl.9019

9019 Background: In many cancer treatment protocols, radiotherapy plays a pivotal role in achieving disease control. A key component of radiotherapy plann...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0732-183X
E-ISSN 1527-7755
Subject Health Sciences
Language English
View Full Journal Page